FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
Reported by American Hospital Association · all stories from aha.org
Editorial digest
The FDA is requesting feedback on possible regulatory strategies for generative artificial intelligence. This specifically concerns medical devices enhanced with AI capabilities.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at American Hospital Association →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/19/2026
FDA seeks feedback on generative AI regulations - MedTech Dive
The FDA is soliciting public input on regulating generative AI technologies.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Reputable trade press8/20/2026
FDA considers ‘competency-based’ evaluations for GenAI-enabled medical devices - MassDevice
The FDA is considering 'competency-based' evaluations for generative AI medical devices.
- Trusted health newsroom8/18/2026
FDA considering doctor-like assessment for AI-enabled devices - Axios
The FDA is considering a doctor-like assessment method for AI-enabled medical devices.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Reputable trade press8/19/2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - Inside Precision Medicine
Most FDA-approved AI medical devices lack strong evidence of direct patient benefit.